ALNYLAM PHARMACEUTICALS INCALNYLAM PHARMACEUTICALS INCALNYLAM PHARMACEUTICALS INC

ALNYLAM PHARMACEUTICALS INC

No trades
See on Supercharts

Price target

3746.280.00 0.00%
The 24 analysts offering 1 year price forecasts for ALNY have a max estimate of — and a min estimate of —.

Analyst rating

Based on 30 analysts giving stock ratings to ALNY in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

ALNY EPS for the last quarter is −18.68 MXN despite the estimation of −20.15 MXN. In the next quarter EPS is expected to reach −18.50 MXN. Track more of ALNYLAM PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter ALNYLAM PHARMACEUTICALS INC revenue is expected to reach ‪7.09 B‬ MXN. Check out ALNYLAM PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, ALNY price target is 3746.28 MXN with a max estimate of 6777.63 MXN and a min estimate of 2333.56 MXN. Check if this forecast comes true in a year, meanwhile keep track of the current situation with ALNY news and stock market news.
We've gathered opinions of 30 analysts rating ALNY stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.